Double Blind, Multicenter, Randomized, Placebo-controlled, Parallel-group, Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Lonicera japonica (Primary)
- Indications Gastritis
- Focus Therapeutic Use
- Sponsors Green Cross
- 02 Jul 2015 Planned End Date changed from 1 Mar 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 02 Jul 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 05 Feb 2015 New trial record